The IκB kinase (IKK) -NF-κB pathway is activated as part of the DNA damage response and controls both resistance to apoptosis and inflammation. How these different functions are achieved remained unknown. We demonstrate here that DNA double strand breaks elicit two subsequent phases of NF-κB activation in vivo and in vitro, which are mechanistically and functionally distinct. RNA-sequencing reveals that the first phase controls anti-apoptotic gene expression, while the second drives expression of senescence-associated secretory phenotype (SASP) genes. The first, rapidly activated phase is driven by the ATM-PARP1-TRAF6-IKK cascade, which triggers proteasomal destruction of IκB and is terminated through IκBα (NFKBIA) reexpression. The second phase is activated days later in senescent cells but is independent of IKK and the proteasome. An altered phosphorylation status of p65, in part driven by GSK3β, results in transcriptional silencing of NFKBIA and IKKindependent, constitutive activation of NF-κB in senescence. Collectively, our study reveals a novel physiological mechanism of NF-κB activation with important implications for genotoxic cancer treatment.
INTRODUCTION
Chemo-and radiotherapies, activated oncogenes and shortened telomeres trigger via the DNA damage response (DDR) a terminal proliferative arrest called cellular senescence (Blagosklonny, 2014; Lasry & Ben-Neriah, 2015; Lee & Schmitt, 2019; Salama et al, 2014) . The associated alterations include formation of senescence associated heterochromatin foci (SAHF), increased expression of cell-cycle inhibitors, including p21 (CDKN1A) and p16 (CDKN2A) and of inflammatory cytokines and chemokines that constitute the senescence associated secretory phenotype (SASP) and a related, low-grade inflammation termed senescence inflammatory response (SIR) that affects surrounding tissues in a paracrine manner (Lasry & Ben-Neriah, 2015; Shelton et al, 1999) . The epigenetically controlled cell-cycle cessation serves as a cellautonomous barrier to tumor formation (Braig et al, 2005; Collado et al, 2005; Reimann et al, 2010) . Therefore, induction of senescence was considered as important in treating cancer and other pathologies. The inflammatory response, however, comprises factors that may instigate oncogenic transformation, cell migration, and cancer stemness (Acosta et al, 2013; Acosta et al, 2008; Chien et al, 2011; Freund et al, 2011; Hoare et al, 2016; Jing et al, 2011; Milanovic et al, 2018; Reimann et al, 2010; Salama et al, 2014) .
The majority of SASP factors are transcriptional targets of NF-κB (Acosta et al, 2008; Chien et al, 2011; Freund et al, 2011; Jing et al, 2011; Kuilman et al, 2008; Lasry & Ben-Neriah, 2015) . Although it is well established that NF-κB drives inflammatory gene expression in senescence, whether it also contributes to cell-cycle arrest remained unclear. DNA double strand breaks lead to rapid activation of NF-κB RelA/p65-p50, the most prevalent heterodimer (Smale, 2012) . A signaling cascade that is activated by ataxia telangiectasia mutated (ATM) and poly(ADP-Ribose) polymerase 1 (PARP1), and also depends on TNFR-associated factor 6 (TRAF6), converges on the IκB kinase (IKK) complex (Hinz et al, 2010; Stilmann et al, 2009; Wu et al, 2006) . The latter is composed of the regulatory IKKγ subunit and the kinases IKKα and IKKβ (Hayden & Ghosh, 2012; Hinz & Scheidereit, 2014) , which phosphorylate IκBα, targeting it for degradation by the 26S proteasome. Liberated NF-κB translocates to the nucleus and activates transcription of its target genes, including NFKBIA, encoding IκBα (Hinz et al, 2012) .
This negative feedback loop ensures that NF-κB activation is transient. Replication-, oncogene-and therapy-induced senescence is associated with unresolved DNA damage and with constitutive NF-κB activation (Chien et al, 2011; Freund et al, 2011; Jing et al, 2011; Rodier et al, 2009 ).
Using cells of epithelial origin, both from transgenic mouse models and from human primary and cancer cell lines, we demonstrate here that DNA damage triggers two functionally distinct phases of NF-κB activation. Whereas the first, immediately activated phase is IKK-and proteasome-dependent and activates anti-apoptotic gene expression, the second NF-κB activation phase, occurring days later in senescence, is caused by a permanent silencing of NFKBIA transcription and is thus IKK-and proteasome-independent. We show that this second, IKK-independent phase of NF-κB is responsible for SASP, but not for the cell cycle arrest. Furthermore, SASP expression profile is generated in vivo and ex vivo in the absence of DNA damage solely by depletion of IκB.
RESULTS

DNA damage activates NF-B d in two distinct phases: A transient anti-apoptotic first and a persistent inflammatory second phase
To investigate the kinetics of activation of NF-κB, we first examined the establishment of senescence and SASP over time in human diploid fibroblasts (HDFs) and cancer cell lines that experienced DNA damage. Onset of senescence was marked by senescenceassociated -galactosidase (SA--gal) activity and elevated p21CIP1 expression ( Fig   1A and Appendix Fig S1A) . Proliferation ceased 1-2 days following irradiation (IR), as expected, and cells entered a lasting senescent state (Appendix Fig S1B and data not shown). Unresolved DNA damage, evidenced by H2AX foci, peaked within minutes and persisted through all time points (Appendix Fig S1C) . Strikingly, the single dose IR generated a biphasic NF-B activation, with two temporally separate phases of nuclear translocation and DNA binding, first, within hours and then days later ( Fig 1B, and Appendix Fig S1C-E ). An RNA-seq analysis revealed distinct transcriptomes in both NF-κB phases ( Fig 1C and Tables EV1A-C). During the first phase, 289 transcripts showed significant upregulation (Table EV1A) , which included direct targets of NF-B, such as early response genes and negative feedback inhibitors of the pathway (NFKBIA and TNFAIP3; see Table EV1B ). This transcript group was enriched for GO terms "cell cycle arrest" and "regulation of apoptotic process" (Table EV2A ). In contrast, the 2,979 transcripts upregulated during the second phase were enriched for GO terms "inflammatory response", "immune response", and "response to wounding" (Fig 1C and   Table EV2B ). The biphasic NF-B response thus coincided with two distinct transcriptomes, an anti-apoptotic first phase and a pro-inflammatory second phase. We next analyzed murine tissues for IR-induced expression of the representative firstand second-phase target genes of NF-κB, Nfkbia and Il6, respectively. IR strongly activated NF-κB in kidney and skin (unpublished data). Indeed, IR significantly induced Nfkbia mRNA in both tissues only at early and Il6 mRNA only at late time points, representing the first and second NF-κB phases ( Fig 1D) .
To ensure that the expression of SASP during the second phase depends on NF-κB, we analyzed primary kidney cells from irradiated mice, which ubiquitously express the NF-κB super-repressor IκBαΔN (Krappmann et al, 1996; Schmidt-Ullrich et al, 2001) .
Compared to littermate controls, expression of Cxcl2 and Il6 in the second phase was abolished, whereas Cdkn1a and Cdkn2a upregulation was unaffected ( Fig 1E) . These in vivo results further reveal that DNA damage activates NF-B that drives SASP, but NF-B is not essential for the proliferative arrest observed in senescence.
A strong response was seen in hair follicles (HF), which require NF-κB activation for development and morphogenesis (Schmidt-Ullrich et al, 2001) . Upregulation of Nfkbia mRNA and IκBα protein was restricted to the first phase of NF-B activation in HF following whole body IR ( Fig 1F and 1G ). At 7 days post IR, IBα expression in the proximal HF was strongly reduced, concomitant with an increase in IL-6 expression in the same region ( Fig 1G) . These results demonstrate that two distinct, subsequent NF-κB transcriptomes also occur in vivo. Because IκBα is required to terminate NF-κB signaling, we postulated that loss of IκBα in senescence could trigger SASP.
Loss of IBα expression in senescence triggers the second phase of NF-B activation and generates SASP
IBα expression was either undetectable or strongly reduced in senescence in the different epithelial cancer-and non-transformed cell lines tested ( Activated oncogenes cause DNA strand breaks and induce DDR signaling, thereby promoting cellular senescence similar to cells exposed to DNA-damaging agents (Acosta et al, 2008; Coppe et al, 2008; Kuilman et al, 2008) . Inducible activation of oncogenic RASV12 led to activation of NF-B and expression of the representative SASP factor IL-8 (encoded by CXCL8) that negatively correlated with IBα expression (Appendix Fig S2F-G) . In summary, these data show that different pro-senescent triggers lead to loss of NFKBIA mRNA expression together with the onset of an NF-Bdriven SASP.
To investigate if experimental NFKBIA depletion would mimic the second phase NF-κB activation and SASP type gene expression, we performed NFKBIA knockdown experiments ( Fig S2J) . However, untreated NFKBIA-depleted cells that had not experienced DNA damage, revealed increased NF-B DNA-binding activity Fig S2J) , consistent with the conclusion that loss of IBα drives expression of SASP.
Remarkably, the transcriptome of non-irradiated NFKBIA-depleted cells shared a strong overlap and the same GO terms with that of the second phase, senescent cells ( Fig 2C and D, and Table EV2B-C). Thus, loss of IBα in the absence of DNA damage is sufficient to generate SASP. Secretion of a set of the identified cytokines and chemokines was confirmed by an antibody array (Appendix Fig S3A) . Some of these, including IL-6 and GM-CSF, activate monocytes and migration of macrophages (Bachelerie et al, 2014) . In fact, supernatants from either senescent or IBα-depleted cells induced migration of macrophages (Appendix Fig S3B) .
We next asked whether knockout of Nfkbia would also trigger SASP in vivo. Since ubiquitous loss of IBα expression causes early postnatal lethality (Beg et al, 1995; Klement et al, 1996) , we generated intestinal epithelium-restricted (villin-Cre x floxed Nfkbia) knockout mice. The expression of selected typical SASP factors, including known NF-B targets Ccl20, ICcam1, Il6 and Tnfa, was indeed activated in the small intestines of knockout compared to control villin-Cre littermates (Fig 2E) , confirming our conclusion in an in vivo setting.
IBα loss in senescence is mediated by posttranslational modifications of p65
Since we observed distinct NF-B targets as upregulated during the two phases (Table   EV1B ), we next knocked down p65 to determine whether the same family member is responsible for both transcriptomes. All NF-B targets, including SASP, showed decrease in expression, in cells bearing shRNA against RELA/p65 ( Fig 3A) .
Nevertheless, knockdown of RELA did not rescue cells from senescence ( Fig 3B) , indicating that it does not contribute to cell cycle arrest.
Since loss of IBα in the second phase resulted from decline of mRNA expression, we investigated its regulation by p65. We found that p65 was recruited to the NFKBIA (IBα) promoter in both first-and second-phases of activation with similar efficiencies (Appendix Fig S4A) . We next investigated the phosphorylation status of p65 during the two phases ( Fig 4A) . Phosphorylation on p65 Ser536, the substrate site of IKK, peaked during the first phase and declined in the second. Unlike phosphorylation of p65 at S536 and S267, which enhance the p65 transactivation potential, phosphorylation at S468 is inhibitory and is mediated in part by GSK3 (Buss H, 2004; Christian F, 2016) . Of note, GSK3β exhibits increased kinase activity in senescence to activate formation of SAHF, through downregulation of Wnt signaling (Ye et al, 2007) . Indeed, nuclear phosphorylation on S468 increased in senescence ( Fig 4A left and right panels). To determine if phosphorylation on S468 repressed expression of IBα, we overexpressed p65 bearing a S468A mutation in cells where endogenous p65 was knocked down.
Overexpression of p65 S468A rescued IκBα expression. Similar results were observed with ectopic expression of wildtype p65, likely due to the abundance of the substrate in relation to the S468 kinase(s). As a negative control, we transfected the S267A mutant.
Since acetylation at S267 is required for p65 activity (Christian F, 2016) , as expected, its overexpression did not rescue IBα in senescence ( Fig 4B) .
To determine directly to which extent GSK3β contributes to phosphorylation of S468, we knocked down GSK3 or inhibited GSK3β by lithium chloride. Both modes of interference diminished S468 phosphorylation and led to a partial restoration of IBα expression in senescence ( Fig 4C and D) . These data show that changes in p65 phosphorylation contribute to an attenuation of IBα expression in senescence.
Second phase NF-κB activation in senescence is independent of IKK-signaling and the proteasome
We next investigated the contribution of the known regulators of the genotoxic stress induced IKK pathway ( Fig 5A) in the two NF-κB phases. The activation of ATM and IKK correlated only with the first NF-κB phase, with rapid IR-induction in the first hours followed by a decline afterwards ( Fig 5B) . We also found that TRAF6 depletion only abrogated activation of the first, but not the second NF-κB phase ( Fig 5C) . Expression of target genes of NF-B, IL6 and IL1A, in the second phase were completely unaffected by depletion of PARP1 or ATM (Appendix Fig S4B and data not shown).
Furthermore, the proteasome inhibitors Bortezomib and MG132 inhibited IR-induced
IκBα destruction in the first NF-κB phase, but not loss of IκBα in the second phase ( Fig   5B) . In line with this, upregulation of the bona-fide SASP component IL-1α was not affected by proteasome inhibition (Fig 5D) .
We eliminated IKKβ expression using CRISPR/Cas9 ( Fig 5E) . Loss of IKK impeded only first phase NF-B activation (Fig 5E, lanes 2 and 6) . Remarkably, IKK was not required for the second phase of NF-B activation ( Fig 5E, lanes 4 and 8) . Likewise, siRNA-mediated IKKγ depletion only diminished p65 nuclear translocation at 1.5 h, but not 5 days following IR (Appendix Fig S4C) .
Our conclusion was further corroborated by identification of genes that depended on p65 expression (Fig 3) , yet showed unaltered expression in senescent cells with CRISPR mediated knockout of IKBKB ( Fig 5F) . These IKK-independent genes included many bona fide SASP factors, such as IL-1α, IL-1β, IL-6, IL8 ( Fig 5F, lower half of the panel). All these data substantiate that only the first phase of NF-κB depends on the IKK cascade induced by DNA damage and on proteasomal destruction of IκBα.
DISCUSSION
Most NF-κB activation pathways depend on IκB kinases (Hinz & Scheidereit, 2014; Hoffmann & Baltimore, 2006) . Here we provide a physiologically relevant context for IKK-independent activation of NF-κB both in human cells lines and in murine models in vivo. We found that in DNA damage induced senescence of epithelial cells, two interconnected events comprising a decline in IKK phosphorylation and a drop in transcription of the inhibitor of the pathway, NFKBIA(IκBα), initiate a persistent, IKKindependent activation of NF-κB (Fig 6) .
We and others have previously shown that irreparable DNA damage leads to cellular senescence and to SASP driven by NF-κB (Chien et al, 2011; Jing et al, 2011; Rodier et al, 2009 ). However, since DNA damage triggers prompt activation of NF-κB, whose immediate transcriptional targets do not feature SASP, it was not clear how NF-κB could be responsible for two such drastically different transcriptomes arising from the same initial stimulus. Here we demonstrated both in vivo and ex vivo that a single dose of DNA damage sequentially activates two temporally and functionally distinct transcriptomes of NF-κB, separated by a span of several days. An anti-apoptotic first phase is driven by an ATM-, PARP-1-and TRAF6-dependent IKK signaling cascade (Hinz et al, 2010; Stilmann et al, 2009 ), resulting in proteasomal destruction of IκBα. A pro-inflammatory second phase occurs in senescence, and comprises SASP ( Fig 6) .
Importantly, we demonstrate that the second phase of NF-κB and expression of the majority of the SASP genes are both IKK-and proteasome-independent. A fraction of transcripts that were IKK-dependent in senescence could be regulated in an alternative manner that does not require phosphorylation in the activation loop of IKKβ. Indeed, we have recently shown that basal activity of IKKβ suffices for its interaction with EDC4 (Enhancer of Decapping 4) and for post-transcriptional stabilization and destabilization of scores of transcripts, including of CXCL8 and TNFA (Mikuda et al, 2018) . It is therefore possible that IKK-dependent regulation of some SASP genes occurs at the level of their RNA stability. It is also possible that additional phosphorylation sites on IKK, not analyzed in this paper, contribute to its activation and to regulation of IKKdependent genes expressed in senescence.
Interestingly, absence of IKK at the instant of DNA damage abolishes only the first phase of NF-κB activation, but does not affect the second phase ( Fig 5E) . This suggests that the first phase is not required for the second, and that the changes accumulated over time activate distinct signaling pathways that enable the second phase of NF-κB. In accordance with this, we show that post-translational modifications on p65 contribute to the two distinct transcriptomes. IKK phosphorylates p65 on serine 536 within minutes following DNA damage (Fig 4) , however in senescence a switch in phosphorylation from serine 536 to 468 leads to repression of NFKBIA. GSK3β, which is hyperactive in senescence (Ye et al, 2007) , phosphorylates p65 at Ser 468. However, inhibition of GSK3β did not completely reinstate IκBα expression, indicating that additional kinases and/or epigenetic changes may contribute to downmodulation of NFKBIA expression in senescence.
Silencing of NFKBIA in senescence results in IKK-independent and persistent activation of NF-κB ( Fig 6) . Consequently, the second phase can be mimicked without induction of DNA damage by inactivation of the NFKBIA gene, as we have shown in human cell cultures and the murine knockout model (Fig 2) . Nonetheless, the gene expression repertoire of NFKBIA knockout or knockdown cell lines does not encompass the entire senescent inflammatory response ( Fig 2C and Table EV1A ) likely because full-featured senescence relies on activation of additional regulators including TORC1, MAPK, Toll Like Receptors, Notch1/TGF-, and C/EBP, and also on epigenetic changes that firmly establish proliferative arrest (Herranz et al, 2015; Hoare et al, 2016; Kolesnichenko et al, 2012; Narita et al, 2011; Serrano, 2012) .
It was previously suggested that in addition to promoting SASP, p65 reinforces cell cycle arrest in senescent Eμ-myc lymphomas expressing the anti-apoptotic protein Bcl-2 (Chien et al, 2011) . However, Bcl-2 was also shown to attenuate cell cycle progression independently of its anti-apoptotic functions (Zinkel et al, 2006) . Our findings clearly demonstrate that although NF-κB negatively regulates expression of several cell cycle genes, knockdown of p65 does not disturb the established cell cycle arrest in epithelial cells and murine model described here (Table EV1A -C and data not shown). Furthermore, we did not observe establishment of senescence either in human cell lines bearing knockdown or knockout of NFKBIA, or in the murine mouse model.
We therefore conclude that NF-κB mediates only the inflammatory phenotype, but not the cell cycle arrest in senescence.
NF-κB is constitutively activated in a variety of cancer types (Ben-Neriah & Karin, 2011).
Deletion of the NFKBIA gene or low expression of IκBα protein serves as a major mechanism of permanent NF-κB activation in a non-classical form of glioblastoma, where it is associated with poor prognosis in patients and resistance to bortezomib and IKK inhibitors in clinical trials (Idbaih et al, 2011; Kinker et al, 2016; Raizer et al, 2016; Takeuchi & Nawashiro, 2011) . Importantly, classical SASP factors and NF-κB targets, such as IL-8, IL-6 and metalloproteinases are constitutively expressed in these tumors, where they are suggested to fuel tumor growth and invasion (Puliyappadamba et al, 2014) . Our results imply that in the milieu of established senescence and concomitant loss of IκBα, inhibition of the IKK-signalosome or the proteasome would be ineffective in suppressing SASP in tumor therapies.
MATERIALS AND METHODS:
Transfection/Transduction: pTRIPz clones IκBα, p65, IKKβ, and IKKy and Scrambled or pGIPZ-IκBα and pGIPZscrambled (Dharmacon, Lafayette, USA) were transfected into HEK293T cells and supernatant used for transduction as described in manufacturer's protocol (http://dharmacon.gelifesciences.com/uploadedfiles/resources/ptripz-inducible-lentiviralmanual.pdf). Clonal selection was performed using puromycin. Doxycycline hydrochloride was added daily (2 µg/ml, Sigma). Unless specified otherwise, dox treatment was done for 5-6 days prior to harvest. As controls, cells inducibly expressing scrambled shRNAs were treated with dox.
CRISPR knockout cells were generated as described previously (Mikuda et al, 2018) .
Preparation of murine tissues from in vivo experiments:
All mouse protocols in this study followed the regulatory standards of the governmental review board (Landesamt Berlin), Reg. G007/08, G 0082/13, G0358/13 and X9013/11). B6;129P2-Nfkbia tm1Kbp and Tg(Vilcre)20Syr) mice were sacrificed at 5 or 7 weeks of age. Additionally, 6 to 8 weeks old C57Bl6/N mice were sacrificed either one hour or 7 days post whole-body IR (5Gy).
Control group was left untreated.
Nuclear Cytoplasmic Fractionation, Western Blot analysis, and EMSA: performed as described previously (Mikuda et al, 2018) .
In situ hybridization: was performed as described previously (Schmidt-Ullrich et al, 2001) .
Antibody Array: Proteome profiler (R&D Systems) antibody array was performed on 1ml of culture medium according to manufacturer's protocol. Quantitation was performed with FusionCapt Advanced software.
Quantitative RT-PCR was performed using a minimum of two reference genes (TBP, Rpl13a, HRTP1) as controls, according to the manufacturer's protocol (Promega). 
RNA-Seq
ACKNOWLEDGEMENTS:
We would like to thank Wei Chen and the MDC sequencing facility for RNA-Seq analysis and Manasa Reddy Gummi, Alexandra Schulze, Lisa Spatt, Nadine Burbach and Kerstin Krueger for excellent assistance. Treatment with Dox was initiated at two days prior to IR (10 Gy) or after IR. through an ATM/TRAF6 and PARP1/PIASy dependent IKK activation mechanism (Hinz et al, 2010; Stilmann et al, 2009; Wu et al, 2006) . (F) Irradiated U2-O2 control and IKBKB knockout cells (as above) were analyzed by qRT-PCR at the time points indicated for expression of NF-κB target genes identified by RNA-Seq (Table EV1 ).
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